MindMotion Go Gamified Neurorehabilitation Platform Receives FDA Clearance

MindMotion Go Gamified Neurorehabilitation
Switzerland-based MindMaze announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its MindMotion Go, a portable neurorehabilitation product, for launch in the United States. MindMotion GO utilizes technology that is designed to be used by patients with mild to lightly severe neurological impairments, as well as those undergoing recovery […]
To access this post, you must purchase Free Subscription, Premium Abo or Premium Abo (6 months).